India Pharma Outlook Team | Thursday, 14 April 2022
Akums Drugs & Pharmaceuticals Ltd has newly acquired a facility from Ankur Drugs and Pharmaceuticals Limited. The facility acquired by Akums Drugs & Pharmaceuticals Ltd is one of largest drug manufacturing facilities in the country. With this acquisition Akums’ will boost its production capacities for general oral tablets and oral liquids.
The planned capacities of the new facility are six billion units of tablets and 90 million units of oral liquids per annum. This facility is most likely to be fully operational by the end of 2022. Sandeep Jain, Founder, Promoter and Director, Akums Drugs & Pharmaceuticals said, “What the addition of this new facility means to our existing network is to step up our nonstop efforts to serve our customers efficiently and the nation better.
With this new facility in Nalagarh in Solan, Himachal Pradesh, we are trying to bridge some more capacity gaps in the pharma industry.” Sanjeev Jain, Founder, Promoter and Director, Akums Drugs & Pharmaceuticals, says, “This extension is a step towards achieving our goal of 20 per cent market share. The operations at our Kotdwar plant have begun recently, while our new plant in Himachal Pradesh is likely to start its operations by December 2022.”